Short answer
Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Earnings release covers three and six months ended June 30, 2026.
Surgery Partners, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers three and six months ended June 30, 2026
- Results and non-GAAP reconciliations available in Exhibit 99.1
- Disclosure furnished under Regulation FD and excluded from Section 18 filing liability protection
Item 7.01 · Regulation FD Disclosure
- Conference call scheduled August 10, 2026 at 8:30 a.m. Eastern for second-quarter and six-month results
- Earnings presentation available through Surgery Partners’ Investor Relations website
- Exhibit 99.2 contains the presentation, providing investors supplemental operating and financial context
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue rose 2.7% to $848.9M, but Adjusted EBITDA fell to $125.2M from $129.0M
- Same-facility revenue growth of 5.0% was driven by 4.8% higher revenue per case, while cases increased only 0.3%
- GAAP net loss attributable to Surgery Partners widened to $15.0M from $2.5M
- Operating cash flow declined to $59.3M from $81.3M, with net leverage at approximately 4.4x EBITDA
- 2026 guidance reaffirmed: revenue $3.35B-$3.45B and Adjusted EBITDA at least $530M, excluding the pending Idaho Falls divestiture
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Surgery Partners, Inc. 8-K filings
Get the next SGRY 8-K as it lands
Follow SGRY for push alerts, or ask the research agent what this filing means.